Center for Substance Abuse Prevention; Notice of Meeting, 52935 [2017-24717]

Download as PDF Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices Terry S. Clark, Asst Information Collection Clearance Officer. [FR Doc. 2017–24671 Filed 11–14–17; 8:45 am] BILLING CODE 4150–04–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings sradovich on DSK3GMQ082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member conflict: Auditory Neuroscience. Date: December 5–6, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John Bishop, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; AREA: Oncological Sciences. Date: December 7, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301–594–7945, kotliars@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Epidemiology of Environmental Exposures, Metabolism, and Kidney, Lung, and Infectious Disease. Date: December 11, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 19:58 Nov 14, 2017 Jkt 244001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: George Vogler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3140, MSC 7770, Bethesda, MD 20892, (301) 237– 2693, voglergp@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pain Mechanisms. Date: December 12–13, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John Bishop, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: November 8, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. 52935 to board members, invited guests, and CSAP staff. Registration will be available for members and invited guests online at https:// snacregister.samhsa.gov/ MeetingList.aspx. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab or by contacting the Designated Federal Officer, Brian Makela. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board. Dates/Time/Type: December 6, 2017, from 10:00 a.m. to 4:00 p.m., EST: CLOSED. Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240–276–2600, Email: brian.makela@samhsa.hhs.gov. [FR Doc. 2017–24685 Filed 11–14–17; 8:45 am] Brian Makela, Chemist, Substance Abuse and Mental Health Services Administration. BILLING CODE 4140–01–P [FR Doc. 2017–24717 Filed 11–14–17; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet via web conference on December 6, 2017. The board will meet in closed session on December 6, 2017, from 10:00 a.m. to 4:00 p.m. EST to discuss proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral Fluid), evaluation of hair as an alternate matrix for drug testing, and future board activities. The meeting will be closed to the public as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). The web conference call-in number and access code will only be available PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 [1651–0114] Agency Information Collection Activities: Crewman’s Landing Permit U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day Notice and request for comments; extension of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. DATES: Comments are encouraged and will be accepted (no later than January 16, 2018) to be assured of consideration. SUMMARY: E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 82, Number 219 (Wednesday, November 15, 2017)]
[Notices]
[Page 52935]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24717]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration

Center for Substance Abuse Prevention; Notice of Meeting

Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory
Board (DTAB) will meet via web conference on December 6, 2017.
The board will meet in closed session on December 6, 2017, from
10:00 a.m. to 4:00 p.m. EST to discuss proposed revisions to the
Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral
Fluid), evaluation of hair as an alternate matrix for drug testing, and
future board activities. The meeting will be closed to the public as
determined by the Assistant Secretary for Mental Health and Substance
Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5
U.S.C. App. 2, Section 10(d).
The web conference call-in number and access code will only be
available to board members, invited guests, and CSAP staff.
Registration will be available for members and invited guests online at
https://snacregister.samhsa.gov/MeetingList.aspx.
Meeting information and a roster of DTAB members may be obtained by
accessing the SAMHSA Advisory Committees Web site, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab or by contacting the Designated Federal Officer, Brian Makela.
Committee Name: Substance Abuse and Mental Health Services
Administration's Center for Substance Abuse Prevention Drug Testing
Advisory Board.
Dates/Time/Type: December 6, 2017, from 10:00 a.m. to 4:00 p.m.,
EST: CLOSED.
Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland
20857.
Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers
Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600,
Email: brian.makela@samhsa.hhs.gov.

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-24717 Filed 11-14-17; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.